Allahabad HC granted bail in a GST prosecution, citing no criminal history, lack of specific material and no demonstrated ...
Earnings call Castle Biosciences delivered Q3 2025 revenue of $83M (+36% YoY for core tests), raised FY25 guidance to $327–$335M, and launched AdvanceAD-Tx targeting a $33B U.S. market. Gross margin ...
Castle Biosciences Inc. company and executive profile by Barron's. View the latest CSTL company infomation and executive bios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results